Literature DB >> 15878632

Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve.

Naoki Kato1, Koichi Nemoto, Kuniaki Nakanishi, Ryuichi Morishita, Yasufumi Kaneda, Maki Uenoyama, Tomosumi Ikeda, Kyosuke Fujikawa.   

Abstract

Hepatocyte growth factor (HGF) is well known to be involved in many biological functions, such as organ regeneration and angiogenesis, and to exert neurotrophic effects on motor, sensory, and parasympathetic neurons. In this study, we gave repeated intramuscular injections of the human HGF gene, using nonviral HVJ (hemagglutinating virus of Japan) liposome method, to examine whether transfection of the rat nervous system with this gene is able to exert neurotrophic effects facilitating recovery of a crushed nerve. The expression of HGF protein and HGF mRNA indicated that gene transfer into the nervous system did occur via retrograde axonal transport. At 4 weeks after crush, electrophysiological examination of the crushed nerve showed a significantly shorter mean latency and a significantly greater mean maximum M-wave amplitude with repeated injections of HGF gene. Furthermore, histological findings showed that the mean diameter of the axons, the axon number and the axon population were significantly larger in the group with repeated injections of HGF gene. The above results show that repeated human HGF gene transfer into the rat nervous system is able to promote crushed-nerve recovery, both electrophysiologically and histologically, and suggest that HGF gene transfer has potential for the treatment of crushed nerve.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878632     DOI: 10.1016/j.neures.2005.04.004

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  9 in total

Review 1.  Advanced Gene-Targeting Therapies for Motor Neuron Diseases and Muscular Dystrophies.

Authors:  Myrsini Chamakioti; Nikolaos Karantzelis; Stavros Taraviras
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

2.  Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: a preliminary study.

Authors:  Hidenori Matsubara; Hiroyuki Tsuchiya; Koji Watanabe; Akihiko Takeuchi; Katsuro Tomita
Journal:  Clin Orthop Relat Res       Date:  2008-09-24       Impact factor: 4.176

3.  Modification of Schwann cell gene expression by electroporation in vivo.

Authors:  Manuela Aspalter; Alka Vyas; Jeffrey Feiner; John Griffin; Thomas Brushart; Richard Redett
Journal:  J Neurosci Methods       Date:  2008-09-11       Impact factor: 2.390

4.  Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor.

Authors:  John A Kessler; Aziz Shaibani; Christine N Sang; Mark Christiansen; David Kudrow; Aaron Vinik; Nari Shin
Journal:  Clin Transl Sci       Date:  2021-02-02       Impact factor: 4.689

5.  Enhanced neuronal Met signalling levels in ALS mice delay disease onset.

Authors:  M Genestine; E Caricati; A Fico; S Richelme; H Hassani; C Sunyach; F Lamballe; G C Panzica; B Pettmann; F Helmbacher; C Raoul; F Maina; R Dono
Journal:  Cell Death Dis       Date:  2011-03-17       Impact factor: 8.469

6.  Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy.

Authors:  John A Kessler; A Gordon Smith; Bong-Soo Cha; Sung Hee Choi; James Wymer; Aziz Shaibani; Senda Ajroud-Driss; Aaron Vinik
Journal:  Ann Clin Transl Neurol       Date:  2015-03-05       Impact factor: 4.511

7.  Conditioned Medium of Bone Marrow-Derived Mesenchymal Stromal Cells as a Therapeutic Approach to Neuropathic Pain: A Preclinical Evaluation.

Authors:  Kelly Barbosa Gama; Dourivaldo Silva Santos; Afrânio Ferreira Evangelista; Daniela Nascimento Silva; Adriano Costa de Alcântara; Ricardo Ribeiro Dos Santos; Milena Botelho Pereira Soares; Cristiane Flora Villarreal
Journal:  Stem Cells Int       Date:  2018-01-30       Impact factor: 5.443

8.  Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo.

Authors:  Naoki Kato; Masahito Matsumoto; Masakazu Kogawa; Gerald J Atkins; David M Findlay; Takahiko Fujikawa; Hiromi Oda; Masato Ogata
Journal:  J Neuroinflammation       Date:  2013-01-03       Impact factor: 8.322

9.  Therapeutic effect of exendin-4, a long-acting analogue of glucagon-like peptide-1 receptor agonist, on nerve regeneration after the crush nerve injury.

Authors:  Koji Yamamoto; Masatoshi Amako; Yoritsuna Yamamoto; Toyokazu Tsuchihara; Hitoshi Nukada; Yasuo Yoshihara; Hiroshi Arino; Masanori Fujita; Maki Uenoyama; Shoichi Tachibana; Koichi Nemoto
Journal:  Biomed Res Int       Date:  2013-08-04       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.